Michael Holder

Michael Holder is an accomplished executive with extensive experience in the healthcare and biotechnology sectors. Currently serving as Chief Executive Officer of Sensable Health since July 2024, Michael focuses on wellness solutions integrating biology, AI, and machine learning. As a Board Member and Chair of the Audit Committee at Cytek Biosciences, and a Board Member at Keyron Medical Technology, Michael contributes to advancing flow cytometry and innovative medical devices for metabolic diseases, respectively. Previous roles include Chief Financial Officer at AVITA Medical and ImmuneCyte, as well as Chief Executive Officer of Longevita BioPharma Partners and Carolina Longevity Institute. Michael's educational background includes an MBA in Corporate Strategy and Finance from The Wharton School and a BBA from UNC Kenan-Flagler Business School.